Skip to search formSkip to main contentSkip to account menu

Refractory anaemia with excess blasts

Known as: Leukemias, Smoldering, Refractory Anemia with Excess Blasts, Smoldering Leukemia 
A myelodysplastic syndrome characterized by the presence of 5-19% myeloblasts in the bone marrow or 2-19% blasts in the peripheral blood. It includes… 
National Institutes of Health

Related topics

Related topics

25 relations
AgranulocytosisAnemiaBone MarrowBone marrow stem cell

Narrower (2)

RAEB-1RAEB-2

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome
Patients with myelodysplastic syndromes (MDS) often show elevated serum ferritin levels at diagnosis, probably caused by… 
2006
2006
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome
Cytokines play an important role in the developmental programs of normal hematopoiesis and leukemia. Signaling through cytokines… 
Highly Cited
2005
Highly Cited
2005
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the… 
Highly Cited
2004
Highly Cited
2004
Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Highly Cited
1996
Highly Cited
1996
Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Highly Cited
1994
Highly Cited
1994
Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
The c-kit proto-oncogene is the receptor gene for the stem cell growth factor. Little is known about the distribution and role of… 
1994
1994
Life expectancy in primary myelodysplastic syndromes: A prognostic score based upon histopathology from bone marrow biopsies of 569 patients
Abstract:  The retrospective evaluation of bone marrow biopsies of 569 patients with primary myelodysplastic syndrome ‐ pMDS… 
Highly Cited
1992
Highly Cited
1992
Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
1992
1992
Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome.
Erythropoiesis in response to erythropoietin (Epo) in myelodysplastic syndrome (MDS) in vitro and in vivo is severely impaired… 
Highly Cited
1987
Highly Cited
1987
French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982–1983 and classified according to FAB criteria
During 1982 and 1983, 4496 new cases were recorded in the French Registry of acute leukemia and myelodysplastic syndromes by the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)